Accuracy, speed, confidence. Introducing generative AI to biopharma.

Simplify the labor-intensive process of collecting, organizing, and inspecting vast amounts of complex data. Get straight to decision-critical insights with 100% confidence, every time.

With our AI-powered data manipulation and verification platform, you'll never lose track of your workstreams again. Gather, refine, and check your data, all in one place.

Get answers in seconds, not hours. Our specialized LLMs enable researchers to perform asset scans 4.8x faster than by hand. †

Our database-scanning algorithm leaves no detail overlooked, making 10x fewer errors than the average analyst or general purpose AI software.

We index over 38M scientific publications, conference abstracts, and clinical trials. All the data you need, when you need it.

Our algorithm learns by reading open-access publications and databases, not your data.

Generate comprehensive competitor reports to stay ahead on trends in endpoints and biomarkers.

Conduct systematic literature reviews for scientific evidence generation.

Forecast market trends and capture emerging business development opportunities.

We are happy to announce the closing of our Seed financing round, co-led by iNovia Ventures and Tola Capital, with participation by Mike Volpi.

At Reliant AI, we believe that the transformative impact of generative AI will be only realized by those willing to take on the world’s biggest information challenges. To make this future come true, we deploy our longstanding expertise in reinforcement learning and natural language processing to some of the hardest problems in pharma, the life sciences and beyond.

We are a global team, driven by a shared mission: leveraging the power of AI to improve the ability of others to excel at their work. Our team of world-leading AI researchers, software engineers and life sciences experts is pushing the state of the art in ML & AI in pursuit of this goal every day.

We are scientists. Builders. Entrepreneurs. We spearheaded many of AI’s most impactful applications. We led teams at Google, DeepMind, and EY Parthenon. We are now bridge cutting-edge AI research and the biopharma industry.